-
-
-
-
-
-
-
Foamix Announces FDA Acceptance of its New Drug Application for FMX103 Minocycline Foam for the Treatment of Moderate-to-Severe Papulopustular Rosacea
-
-
-
-
-
-
-
Foamix Reports Second Quarter 2019 Financial Results and Provides Corporate Update
-
-
-
-
-
-
-
Pre-Open Movers 09/13: (PI) (XBIT) (GNC) Higher; (PVTL) (PGNX) (FRED) Lower (more...)
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

